tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of David Nierengarten, 314 are a BUY (81.56%), 69 are a HOLD (17.92%), 2 are a SELL (0.52%).
Analyst David Nierengarten, currently employed at WEDBUSH, carries an average stock price target met ratio of 46.18% that have a potential upside of 47.33% achieved within 205 days.
David Nierengarten’s has documented 854 price targets and ratings displayed on 66 stocks. The coverage is on Healthcare, Communication Services, Technology sectors.
Most recent stock forecast was given on GBIO, Generation Bio Co at 16-Dec-2025.
Analyst best performing recommendations are on SRRK (SCHOLAR ROCK HOLDING CORP).
The best stock recommendation documented was for SRRK (SCHOLAR ROCK HOLDING CORP) at 6/18/2018. The price target of $25 was fulfilled within 1 day with a profit of $3.57 (16.66%) receiving and performance score of 166.59.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
Since 07-Jan-2026
$70
$25.33 (56.70%)
$20
8 days ago
(07-Jan-2026)
7/13 (53.85%)
$26.09 (59.42%)
129
Buy
Since 04-Jun-2025
$51
$6.33 (14.17%)
$52
1 months 22 days ago
(24-Nov-2025)
4/12 (33.33%)
$9.05 (21.57%)
72
Buy
Since 21-Feb-2024
$80
$35.33 (79.09%)
$55
2 months 17 days ago
(29-Oct-2025)
1/3 (33.33%)
$43.88 (121.48%)
670
Buy
Since 10-May-2024
$70
$25.33 (56.70%)
$40
3 months ago
(15-Oct-2025)
13/19 (68.42%)
$35.74 (104.32%)
147
Buy
Since 19-Jul-2024
$80
$35.33 (79.09%)
$42
5 months 22 days ago
(24-Jul-2025)
9/14 (64.29%)
$53.01 (196.41%)
488
Which stock is David Nierengarten is most bullish on?
Which stock is David Nierengarten is most reserved on?
What Year was the first public recommendation made by David Nierengarten?
